EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nontumor‐Specific mRNA Sensitization of Cold Tumors to Immune Checkpoint Blockade: Evidence, Bias, and Requirements for Translation

Sarfaraz K. Niazi

Advanced Oncology · 2026

DOI: 10.1002/adon.70007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Oncology, 2026. Verfasst von Sarfaraz K. Niazi. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nontumor‐specific messenger RNA may sensitize cold tumors to checkpoint blockade, but survival estimates are heterogeneous, bias‐aligned analyses reveal no difference, and spreading is unproven.

Zitieren

APA

Niazi, S. K. (2026). Nontumor‐Specific mRNA Sensitization of Cold Tumors to Immune Checkpoint Blockade: Evidence, Bias, and Requirements for Translation. Advanced Oncology. https://doi.org/10.1002/adon.70007

Vancouver

Niazi SK. Nontumor‐Specific mRNA Sensitization of Cold Tumors to Immune Checkpoint Blockade: Evidence, Bias, and Requirements for Translation. Advanced Oncology. 2026. doi:10.1002/adon.70007

BibTeX
@article{Niazi2026,
  author = {Niazi, Sarfaraz K.},
  title = {Nontumor‐Specific mRNA Sensitization of Cold Tumors to Immune Checkpoint Blockade: Evidence, Bias, and Requirements for Translation},
  journal = {Advanced Oncology},
  year = {2026},
  doi = {10.1002/adon.70007}
}
Kostenlos starten →